EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO
发明人:
Robert Vink
申请号：
US14902228
公开号：
US20160136160A1
申请日:
2014.07.02
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to a method of preventing and/or treating chronic traumatic encephalopathy by administering to a subject N-(3,5-Bis-trifluoromethyl-benzyl)-N-methyl-6-(piperazin-1-yl)-4-o-tolyl nicotinamide or 4-alkyl-piperazin-1-yl derivatives thereof.
